These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6526557)

  • 1. The basement membrane autoantigen in epidermolysis bullosa acquisita.
    Fine RM
    Int J Dermatol; 1984 Dec; 23(10):646. PubMed ID: 6526557
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.
    Woodley DT; Briggaman RA; O'Keefe EJ; Inman AO; Queen LL; Gammon WR
    N Engl J Med; 1984 Apr; 310(16):1007-13. PubMed ID: 6369131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the epidermolysis bullosa acquisita antigen by LH 7.2 monoclonal antibody: use in diagnosis.
    Tatnall FM; Whitehead PC; Black MM; Wojnarowska F; Leigh IM
    Br J Dermatol; 1989 Apr; 120(4):533-9. PubMed ID: 2730844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen.
    Barton DD; Fine JD; Gammon WR; Sams WM
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 2):369-73. PubMed ID: 3525621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ-specific, phylogenetic, and ontogenetic distribution of the epidermolysis bullosa acquisita antigen.
    Paller AS; Queen LL; Woodley DT; Lane AT; Gammon WR; Briggaman RA
    J Invest Dermatol; 1986 Apr; 86(4):376-9. PubMed ID: 3745957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermolysis bullosa acquisita with negative direct immunofluorescence.
    Lacour JP; Ortonne JP
    Arch Dermatol; 1986 Sep; 122(9):972. PubMed ID: 3527078
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains.
    Woodley DT; O'Keefe EJ; Reese MJ; Mechanic GL; Briggaman RA; Gammon WR
    J Invest Dermatol; 1986 Jun; 86(6):668-72. PubMed ID: 3519786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional heterogeneity of immune complexes in epidermolysis bullosa acquisita.
    Gammon WR; Briggaman RA
    J Invest Dermatol; 1987 Nov; 89(5):478-83. PubMed ID: 3668292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen.
    Woodley DT; O'Keefe EJ; McDonald JA; Reese MJ; Briggaman RA; Gammon WR
    J Clin Invest; 1987 Jun; 79(6):1826-30. PubMed ID: 3584471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermolysis bullosa acquisita antigen is synthesized by human keratinocytes cultured in serum-free medium.
    Woodley DT; Briggaman RA; Gammon WR; O'Keefe EJ
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1267-72. PubMed ID: 2411267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical distribution and immunological characteristics of epidermolysis bullosa acquisita antigen and bullous pemphigoid antigen.
    Furue M; Iwata M; Tamaki K; Ishibashi Y
    Br J Dermatol; 1986 Jun; 114(6):651-9. PubMed ID: 3521710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies.
    Zhu XJ; Niimi Y; Bystryn JC
    Arch Dermatol; 1990 Feb; 126(2):171-4. PubMed ID: 2134155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
    Peng TK; Nisengard RJ; Levine MJ; Beutner EH
    Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen.
    Paller AS; Queen LL; Woodley DT; Gammon WR; O'Keefe EJ; Briggaman RA
    J Invest Dermatol; 1985 Mar; 84(3):215-7. PubMed ID: 3882847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearing of epidermolysis bullosa acquisita with cyclosporine.
    Crow LL; Finkle JP; Gammon WR; Woodley DT
    J Am Acad Dermatol; 1988 Nov; 19(5 Pt 2):937-42. PubMed ID: 3057000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer.
    Furue M; Iwata M; Yoon HI; Kubota Y; Ohto H; Kawashima M; Tsuchida T; Oohara K; Tamaki K; Kukita A
    J Am Acad Dermatol; 1986 May; 14(5 Pt 2):873-8. PubMed ID: 3086389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunopathology of epidermolysis bullosa acquisita.
    Kushniruk W
    Can Med Assoc J; 1973 May; 108(9):1143-6. PubMed ID: 4574408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl.
    Rubenstein R; Esterly NB; Fine JD
    Arch Dermatol; 1987 Jun; 123(6):772-6. PubMed ID: 3555356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermolysis bullosa acquisita antigen: relationship between the collagenase-sensitive and -insensitive domains.
    Yoshiike T; Woodley DT; Briggaman RA
    J Invest Dermatol; 1988 Feb; 90(2):127-33. PubMed ID: 2828479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.